Equillium (EQ) Operating Income (2018 - 2026)
Equillium (EQ) reported Operating Income of -$5.6 million for Q1 2026, up 36.75% year-over-year from -$4.1 million in Q1 2025, and down 137.48% quarter-over-quarter from $15.0 million in Q4 2025.
Equillium (EQ) Operating Income (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Operating Income data on file, last reported at -$5.6 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$5.6 million, up 36.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 81.22% YoY), and the FY2025 annual result was -$4.7 million, down 190.73% from the prior year.
- Operating Income declined to -$5.6 million in Q1 2026 per EQ's latest filing, from $15.0 million in the prior quarter.
- Over five years, Operating Income peaked at $15.0 million in Q4 2025 and troughed at -$37.3 million in Q1 2022.
- A 5-year average of -$5.2 million and a median of -$3.6 million in 2023 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 666.41% in 2025 and fell as far as 6128.0% in 2025.
- A 5-year view of Operating Income shows it stood at $2.0 million in 2022, then tumbled by 256.71% to -$3.2 million in 2023, then jumped by 161.03% to $2.0 million in 2024, then jumped by 666.41% to $15.0 million in 2025, then slumped by 137.48% to -$5.6 million in 2026.
- Business Quant data shows EQ's Operating Income at -$5.6 million in Q1 2026, $15.0 million in Q4 2025, and -$4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | -5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.61 Mn |
| Dec 31, 2025 | 14.97 Mn |
| Sep 30, 2025 | -4.58 Mn |
| Jun 30, 2025 | -6.23 Mn |
| Mar 31, 2025 | -8.87 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | -679,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Mar 31, 2024 | -2.79 Mn |
| Dec 31, 2023 | -3.20 Mn |
| Sep 30, 2023 | -3.62 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Mar 31, 2023 | -4.11 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | -13.24 Mn |
| Jun 30, 2022 | -13.55 Mn |
| Mar 31, 2022 | -37.33 Mn |
| Dec 31, 2021 | -10.39 Mn |
| Sep 30, 2021 | -9.86 Mn |
| Jun 30, 2021 | -8.84 Mn |